Legend-Related Investment Firm Joins Funding Round In Gene Therapy Start-Up Exegenesis

For Digital Subscribers Only
Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule.

Gene therapy start-up Exegenesis Bio Inc. has completed tens of millions of USD in a funding round led by K2 venture partners, one of venture capital units of Chinese investment firm K2VC, according to Chinese media outlet 36Kr.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

RELATED NEWS



LEAVE A REPLY